Notably, mutated genes that contribute to the aggressive nature of the cancer include breast cancer (BRCA) type1/2, the Small Mother Against Decapentaplegic (SMAD)4, the tumor protein (TP)53, and the cyclin dependent kinase inhibitor (CDKN)2A. The gene discussed is TP53; the disease is cancer.